Umbilical cord-derived mesenchymal stem cells for COVID-19 patients with acute respiratory distress syndrome (ARDS)

Umbilical cord-derived mesenchymal stem cells for COVID-19 patients with acute respiratory distress syndrome (ARDS)

The coronavirus SARS-CoV-2 is cause of a global pandemic of a pneumonia-like disease termed Coronavirus Disease 2019 (COVID-19). COVID-19 presents a high mortality rate, estimated at 3.4%. More than 1 out of 4 hospitalized COVID-19 patients require admission to an Intensive Care Unit (ICU) for respi...

Full description

Bibliographic Details
Main Authors:	G. Lanzoni, E. Linetsky, D. Correa, R. Alvarez, A. Marttos, K. Hirani, S. Messinger Cayetano, J. Castro, M. Paidas, J. Efantis Potter, X. Xu, M. Glassberg, J. Tan, A. Patel, G. Goldstein, N. Kenyon, D. Baidal, R. Alejandro, R. Vianna, P. Ruiz, A. Caplan, C. Ricordi
Format:	Article
Language:	English
Published:	Verduci Editore 2020-04-01
Series:	CellR4
Subjects:	umbilical cord-derived mesenchymal stem cells (uc-mscs) coronavirus disease 2019 (covid-19) acute respiratory distress syndrome (ards)
Online Access:	https://www.cellr4.org/wp-content/uploads/sites/2/2020/04/e2839-Umbilical-Cord-derived-Mesenchymal-Stem-Cells-for-COVID-19-Patients-with-Acute-Respiratory-Distress-Syndrome-ARDS.pdf

Similar Items

Whole transcriptome scanning and validation of negatively related genes in UC-MSCs
by: Linghan Tian, et al.
Published: (2024-03-01)

Mesenchymal stem cells and their derived exosomes for ALI/ARDS: A promising therapy
by: Dan Liang, et al.
Published: (2023-10-01)

Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS
by: Zhiheng Xu, et al.
Published: (2021-10-01)

Mesenchymal stem cells as a potential therapy for COVID-19
by: Shan Liu, et al.
Published: (2020-05-01)

Comparison of CD146 +/− mesenchymal stem cells in improving premature ovarian failure
by: Lin Zhang, et al.
Published: (2022-06-01)

Umbilical Cord Mesenchymal-Stem-Cell-Derived Exosomes Exhibit Anti-Oxidant and Antiviral Effects as Cell-Free Therapies
by: Yi Meng, et al.
Published: (2023-10-01)

CD146+ Umbilical Cord Mesenchymal Stem Cells Exhibit High Immunomodulatory Activity and Therapeutic Efficacy in Septic Mice
by: Zhang L, et al.
Published: (2023-02-01)

Umbilical cord-derived mesenchymal stem cells on scaffolds facilitate collagen degradation via upregulation of MMP-9 in rat uterine scars
by: Lu Xu, et al.
Published: (2017-04-01)

Broadness and specificity: ArdB, ArdA, and Ocr against various restriction-modification systems
by: Anna A. Kudryavtseva, et al.
Published: (2023-04-01)

Observational case-control study of non-invasive ventilation in patients with ARDS
by: G. Domenighetti, et al.
Published: (2016-01-01)

Human Umbilical Cord Mesenchymal Stem Cells for Adjuvant Treatment of a Critically Ill COVID-19 Patient: A Case Report
by: Zhu Y, et al.
Published: (2020-09-01)

Corrigendum: Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: a systematic review and meta-analysis
by: Cong-wen Yang, et al.
Published: (2024-01-01)

Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: A systematic review and meta-analysis
by: Cong-wen Yang, et al.
Published: (2022-08-01)

Umbilical Cord Mesenchymal Stromal/Stem Cells and Their Interplay with Th-17 Cell Response Pathway
by: Mehdi Najar, et al.
Published: (2024-01-01)

TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation
by: Fan Ding, et al.
Published: (2024-02-01)

hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
by: Fengbiao Guo, et al.
Published: (2023-08-01)

Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice
by: Xiaodan Lv, et al.
Published: (2021-09-01)

Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease
by: Qinjun Zhao, et al.
Published: (2019-11-01)

Effects of methyl prednisolone in early ARDS
by: Nasef Abdelsalam Rezk, et al.
Published: (2013-01-01)

Antioxidants Improve the Proliferation and Efficacy of hUC-MSCs against H<sub>2</sub>O<sub>2</sub>-Induced Senescence
by: Zhaojuan Zheng, et al.
Published: (2023-06-01)

CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy
by: Sohsuke Meshitsuka, et al.
Published: (2022-12-01)

Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling
by: Yulin He, et al.
Published: (2021-07-01)

Factors associated with oxygenation improvement in children with ARDS
by: Abdul Chairy, et al.
Published: (2014-02-01)

COVID-19 disease treatment: pivotal challenges in the arena of umbilical cord-mesenchymal stem cells (UC-MSCs)
by: Al-Hassan Soliman, et al.
Published: (2023-05-01)

Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment
by: Dragan Primorac, et al.
Published: (2021-09-01)

Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic
by: Xiaoli Zhuang, et al.
Published: (2023-08-01)

Intrapulmonary autologous transplant of bone marrow-derived mesenchymal stromal cells improves lipopolysaccharide-induced acute respiratory distress syndrome in rabbit
by: Mohammad Reza Mokhber Dezfouli, et al.
Published: (2018-12-01)

One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment
by: Lei Shi, et al.
Published: (2022-07-01)

COVID-19 pneumonia: ARDS or not?
by: Luciano Gattinoni, et al.
Published: (2020-04-01)

Pronation Technique in ARDS Patients
by: Raffaele Di Fenza, et al.
Published: (2020-07-01)

An Overview on Mesenchymal Stem Cells Derived from Extraembryonic Tissues: Supplement Sources and Isolation Methods
by: Salehinejad P, et al.
Published: (2020-07-01)

MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus
by: Dan Li, et al.
Published: (2020-05-01)

Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase
by: Lu Zhang, et al.
Published: (2018-02-01)

Peptidome analysis of umbilical cord mesenchymal stem cell (hUC-MSC) conditioned medium from preterm and term infants
by: Yu Wang, et al.
Published: (2020-09-01)

Septicemia Induced ARDS Mimicking Transfusion Related Acute Lung Injury
by: Sudhir Kumar Vujhini1 , Narendra Kumar Narahari2 , Shanthi B3
Published: (2018-08-01)

Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-β1
by: Wang Chun, et al.
Published: (2021-09-01)

How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
by: Sami Hraiech, et al.
Published: (2017-08-01)

Age of Red Cells for Transfusion and Outcomes in Patients with ARDS
by: Jan A. Graw, et al.
Published: (2022-01-01)

Early vvECMO implantation may be associated with lower mortality in ARDS
by: Peter Rosenberger, et al.
Published: (2023-09-01)

A case report of fatal disseminated fungal sepsis in a patient with ARDS and extracorporeal membrane oxygenation
by: Stefanie Prohaska, et al.
Published: (2020-05-01)